Position in OGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$256,258
+$142,892 QoQ
Shares Held
18,926
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#220
of 626 holders
Holding Since
Jun 2021
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DNB Asset Management AS holds $1,056,869,643 across 10 Drug Manufacturers - General names. OGN ranks #10 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
322,831 | $387,213,218 | |
| 2 | JNJ |
Johnson & Johnson
|
761,144 | $193,307,741 | |
| 3 | ABBV |
AbbVie Inc.
|
610,909 | $153,729,140 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,009,058 | $129,663,953 | |
| 5 | PFE |
Pfizer Inc
|
2,338,682 | $56,315,462 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
851,719 | $49,076,048 | |
| 7 | AMGN |
Amgen Inc
|
122,834 | $44,480,648 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
285,591 | $36,081,566 |
All Filings in OGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $256,258 | 18,926 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $113,366 | 18,926 | Shares | Other | 2026-05-14 | |
| 2021-06-30 | $400,491 | 13,235 | Shares | Other | 2021-07-06 | |
| No filing history on record for this holder in this stock. | ||||||